IDX184
IDX184 is a potent and orally bioavailable inhibitor of HCV replication. IDX184 potently inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 nM) [1][2].
Product Specifications
CAS Number
1036915-08-8
UNSPSC
12352005
Target
HCV; HCV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/idx184.html
Purity
99.80
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
C[C@]([C@](O[C@@H]1CO[P](NCC2=CC=CC=C2)(OCCSC(C(C)(C)CO)=O)=O)([H])N3C(NC(N)=NC4=O)=C4N=C3)([C@@H]1O)O
Molecular Formula
C25H35N6O9PS
Molecular Weight
626.62
References & Citations
[1]Xiao-Jian Zhou , et al. Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy Subjects. Antimicrob Agents Chemother. 2011 Jan;55 (1) :76-81.|[2]IN VITRO ANTIVIRAL ACTIVITY AND PHARMACOLOGY OF IDX184, A NOVEL AND POTENT INHIBITOR OF HCV REPLICATION.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9905288 Inquire
Goat Leucine-Rich Repeat and Calponin Homology Domain-Containing 4 (LRCH4) ELISA Kit
Sign In for Pricing
View Details 
A51412-100UG 100 µg
Ribosome-inactivating protein alpha-trichosanthin Antibody, HRP conjugated
Sign In for Pricing
View Details GTR15390353 1 Vial
Lentiviral human ACTR6 sgRNA gene knockout kit - Lentiviral human ACTR6 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 